We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Inactive Receptor Hinders Immunotherapy Effectiveness

News   Oct 16, 2019 | Original story from the Technical University of Munich

 
Inactive Receptor Hinders Immunotherapy Effectiveness

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

"Invisible" Stem Cells Evade Natural Killer Cells Using Immune Off-Switch

News

UC San Francisco scientists have discovered a new way to control the immune system's natural killer cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The findings could also be used to enhance the ability of cancer immunotherapies to detect and destroy lurking tumors.

READ MORE

Why Cancer Patients With Liver Metastases Have a Poor Response to Immunotherapy

News

Using multiple mouse models, researchers demonstrate that liver metastases are able to siphon activated CD8+ T cells from the systemic circulation and recruit immunosuppressive macrophages capable of promoting T cell death within the liver. The study, published in Nature Medicine, could be key to understanding why patients with liver metastases typically have a poor response to immunotherapy.

READ MORE

Boosting T Cells’ Ability To Attack Solid Tumors

News

Boosting the immune system's T cells to effectively attack solid tumors can be achieved by adding a small molecule to an immunotherapeutic strategy known as chimeric antigen receptor-T (CAR-T) cell therapy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE